These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 12071440)

  • 1. Production of non-pathogenic human monoclonal antibodies to desmoglein 3 from pemphigus vulgaris patient.
    Bhol KC; Ahmed AR
    Autoimmunity; 2002 Mar; 35(2):87-91. PubMed ID: 12071440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibodies against keratinocyte antigens other than desmogleins 1 and 3 can induce pemphigus vulgaris-like lesions.
    Nguyen VT; Ndoye A; Shultz LD; Pittelkow MR; Grando SA
    J Clin Invest; 2000 Dec; 106(12):1467-79. PubMed ID: 11120754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isotypes and antigenic profiles of pemphigus foliaceus and pemphigus vulgaris autoantibodies.
    Hacker MK; Janson M; Fairley JA; Lin MS
    Clin Immunol; 2002 Oct; 105(1):64-74. PubMed ID: 12483995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The anti-desmoglein 1 autoantibodies in pemphigus vulgaris sera are pathogenic.
    Ding X; Diaz LA; Fairley JA; Giudice GJ; Liu Z
    J Invest Dermatol; 1999 May; 112(5):739-43. PubMed ID: 10233765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neonatal pemphigus vulgaris: IgG4 autoantibodies to desmoglein 3 induce skin blisters in newborns.
    Parlowsky T; Welzel J; Amagai M; Zillikens D; Wygold T
    J Am Acad Dermatol; 2003 Apr; 48(4):623-5. PubMed ID: 12664033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucosal and mucocutaneous (generalized) pemphigus vulgaris show distinct autoantibody profiles.
    Ding X; Aoki V; Mascaro JM; Lopez-Swiderski A; Diaz LA; Fairley JA
    J Invest Dermatol; 1997 Oct; 109(4):592-6. PubMed ID: 9326396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenic human monoclonal antibody against desmoglein 3.
    Yeh SW; Cavacini LA; Bhol KC; Lin MS; Kumar M; Duval M; Posner MR; Ahmed AR
    Clin Immunol; 2006 Jul; 120(1):68-75. PubMed ID: 16635589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenicity and Epitope Characteristics Do Not Differ in IgG Subclass-Switched Anti-Desmoglein 3 IgG1 and IgG4 Autoantibodies in Pemphigus Vulgaris.
    Lo AS; Mao X; Mukherjee EM; Ellebrecht CT; Yu X; Posner MR; Payne AS; Cavacini LA
    PLoS One; 2016; 11(6):e0156800. PubMed ID: 27304671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a new antibody population directed against a desmosomal plaque antigen in pemphigus vulgaris and pemphigus foliaceus.
    Joly P; Gilbert D; Thomine E; Zitouni M; Ghohestani R; Delpech A; Lauret P; Tron F
    J Invest Dermatol; 1997 Apr; 108(4):469-75. PubMed ID: 9077476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of antigen-specific B cells in patients with pemphigus vulgaris by enzyme-linked immunospot assay: requirement of T cell collaboration for autoantibody production.
    Nishifuji K; Amagai M; Kuwana M; Iwasaki T; Nishikawa T
    J Invest Dermatol; 2000 Jan; 114(1):88-94. PubMed ID: 10620121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunologic and histopathologic characterization of an active disease mouse model for pemphigus vulgaris.
    Ohyama M; Amagai M; Tsunoda K; Ota T; Koyasu S; Hata J; Umezawa A; Nishikawa T
    J Invest Dermatol; 2002 Jan; 118(1):199-204. PubMed ID: 11851895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The distribution of pemphigus vulgaris-IgG subclasses and their reactivity with desmoglein 3 and 1 in pemphigus patients and their first-degree relatives.
    Kricheli D; David M; Frusic-Zlotkin M; Goldsmith D; Rabinov M; Sulkes J; Milner Y
    Br J Dermatol; 2000 Aug; 143(2):337-42. PubMed ID: 10951142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-desmoglein 1 antibodies in Tunisian healthy subjects: arguments for the role of environmental factors in the occurrence of Tunisian pemphigus foliaceus.
    Kallel Sellami M; Ben Ayed M; Mouquet H; Drouot L; Zitouni M; Mokni M; Cerruti M; Turki H; Fezza B; Mokhtar I; Ben Osman A; Zahaf A; Kamoun MR; Joly P; Masmoudi H; Makni S; Tron F; Gilbert D
    Clin Exp Immunol; 2004 Jul; 137(1):195-200. PubMed ID: 15196262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relevance of differential immunogenicity of human and mouse recombinant desmoglein-3 for the induction of acantholytic autoantibodies in mice.
    Kaithamana S; Fan JL; Memar O; Li K; Uitto J; Seetharamaiah GS; Prabhakar BS
    Clin Exp Immunol; 2003 Apr; 132(1):16-23. PubMed ID: 12653831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic and functional characterization of human pemphigus vulgaris monoclonal autoantibodies isolated by phage display.
    Payne AS; Ishii K; Kacir S; Lin C; Li H; Hanakawa Y; Tsunoda K; Amagai M; Stanley JR; Siegel DL
    J Clin Invest; 2005 Apr; 115(4):888-99. PubMed ID: 15841178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of anti-desmocollins I and II autoantibodies in two cases of Hallopeau type pemphigus vegetans by immunoblot analysis.
    Hashimoto K; Hashimoto T; Higashiyama M; Nishikawa T; Garrod DR; Yoshikawa K
    J Dermatol Sci; 1994 Apr; 7(2):100-6. PubMed ID: 8060912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoadsorption of Desmoglein-3-Specific IgG Abolishes the Blister-Inducing Capacity of Pemphigus Vulgaris IgG in Neonatal Mice.
    Hofrichter M; Dworschak J; Emtenani S; Langenhan J; Weiß F; Komorowski L; Zillikens D; Stöcker W; Probst C; Schmidt E; Goletz S
    Front Immunol; 2018; 9():1935. PubMed ID: 30233569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunofluorescence and immunoblot studies on the reactivity of pemphigus vulgaris and pemphigus foliaceus sera with desmoglein 3 and desmoglein 1.
    Hashimoto T; Amagai M; Garrod DR; Nishikawa T
    Epithelial Cell Biol; 1995; 4(2):63-9. PubMed ID: 8688919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A subset of pemphigus foliaceus patients exhibits pathogenic autoantibodies against both desmoglein-1 and desmoglein-3.
    Arteaga LA; Prisayanh PS; Warren SJ; Liu Z; Diaz LA; Lin MS;
    J Invest Dermatol; 2002 May; 118(5):806-11. PubMed ID: 11982757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoimmunity to desmocollin 3 in pemphigus vulgaris.
    Mao X; Nagler AR; Farber SA; Choi EJ; Jackson LH; Leiferman KM; Ishii N; Hashimoto T; Amagai M; Zone JJ; Payne AS
    Am J Pathol; 2010 Dec; 177(6):2724-30. PubMed ID: 20952584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.